Millipore

Rockland Immunochemicals is a global biotechnology company manufacturing leading edge research tools and cGMP grade proteins for basic, applied and clinical research in functional genomics, gene therapy and drug discovery markets. Rockland operates outside of Philadelphia. European and Asian markets are supported through a highly specialized network of key distributors. Rockland s antibodies are suited for individuals performing high throughput screening, drug discovery, diagnostic kit production and life science research. Primary antibodies include apolipoproteins, apoptosis/cell cycle, cytokines, cell signaling, enzymes, extracellular matrix, transcription factors (NFkB) and ubiquitin. Secondary antibodies are conjugated to a broad range of enzymes, fluorphors and magnetic particles.

Celldex Therapeutics is a biopharmaceutical company that applies its Immunotherapy Platform to treat various diseases. Its immunotherapy platform includes a complementary portfolio of monoclonal antibodies, antibody-targeted vaccines and immunomodulators to create novel disease-specific drug candidates. Celldex Therapeutics technology platform uses human monoclonal antibodies administered directly to patients to target dendritic cells and macrophages that are key cells in the immune system. Its APC Targeting Technology delivers an antigen that results in more efficient processing than a nontargeted antigen. The company develops various therapeutic human monoclonal antibody products. Its lead programs are for oncology targets. Celldex Therapeutics has two clinical programs under clinical evaluation for the therapy of cancer.

Monera Technologies Corp, based in Allentown, PA, is a leading provider of specialized microbial cultures and innovative solutions for biological wastewater treatment. With a focus on environmentally sound biotreatment and waste analysis, Monera has successfully deployed its products on six continents for municipalities, industries, aquaculture, hospitality, agriculture, and residential applications. For over three decades, Monera has been at the forefront of helping businesses and individuals solve their most challenging wastewater issues through the deployment of cutting-edge microbial technologies. Their proven success in bioaugmentation, process improvement, and stabilization makes them a trusted leader in the field of microbial wastewater treatment solutions. Generated from the website